Strategic Opportunities Committee


President-Elect and Chair
Maria Arcila, MD
Memorial Sloan Kettering Cancer Center (MSKCC)

Molecular pathology exists within a rapidly changing environment. The Strategic Opportunities Committee asseses the opportunities and challenges in the molecular pathology profession and other environments external to the organization that affect AMP interests.

The Strategic Opportunities Committee carries out the activities listed below and provides relevant reports and recommendations to the Board of Directors:

  • Assessing trends and activities in the broad environment external to AMP, i.e., "Horizon Scanning";
  • Identifying and assessing external threats that could prevent AMP from attaining its goals;
  • Identifying and assessing external opportunities that can help AMP attain its goals;
  • Identifying organizations for potential relationships that can help AMP attain its goals.


Committee Members

If you are interested in serving on the Strategic Opportunities Committee, please see the various roles available and the responsibilities of each role by clicking here.

Maria Arcila, MD
Memorial Sloan Kettering Cancer Center (MSKCC)

Board Member (2022-2023)
Alexis Carter, MD
Children’s Hospital of Atlanta

Member (2022-2023)
Michael Hadjisavas, PhD

Member (2022-2023)
Robert L. Nussbaum, MD

Member (2022-2023)
Jill Hagenkord, MD
Optum Genomics

Member (2022-2023)
Jordan Laser, MD

Member (2022-2023)
Anthony N. Sireci, MD, MS

Ex Officio Committee Members

Laura J. Tafe, MD
Dartmouth Hitchcock Medical Center

Executive Director (Non-Voting)
Mary Steele Williams, MNA, MT(ASCP)SM

Corporate Partners